Moxibustion for alleviating abdominal pain and distension in IBS-D patients: a randomized, controlled trial
Phase 1
- Registration Number
- TCTR20230112006
- Lead Sponsor
- Meiya Xu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 164
Inclusion Criteria
1)met the Rome III diagnostic criteria and Bristol Form Scale for IBS-C; 2)were 18-65 years old; 3) had IBS-D for more than 6 months; 4) had a baseline IBS-Symptom Severity Score (IBS-SSS) of 75 or higher; 5)were with signed informed consent.
Exclusion Criteria
1)were accompanied with inflammatory bowel disease, intestinal organic lesions, peptic ulcer, infectious diarrhea; 2) were accompanied with serious cardiovascular or cerebrovascular diseases, or severe liver or kidney dysfunction; 3) were pregnant or had reproductive plan within 1 month; 4) had participated in other clinical trials 1 month before.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IBS-SSS from week 0 to week 6 6 weeks changes in total IBS-SSS from week 0 to week 6
- Secondary Outcome Measures
Name Time Method IBS-SSS from week 6 to week 18 18 weeks changes in total IBS-SSS from week 6 to week 18